Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Chin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancers|March 19, 2020
Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with <i>RET</i> RearrangementsSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.
Clinical Lung Cancer|November 12, 2019
Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung CancerSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2019
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLCIbiayi Dagogo-Jack, Marguerite Rooney, Rebecca J Nagy, et al.
Retrovirology|October 26, 2013
T cell response specificity and magnitude against SIVmac239 are not concordant in major histocompatibility complex-matched animalsBrian T Cain, Ngoc H Pham, Melisa L Budde, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung CancerJessica J Lin, Emily Chin, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation DiversityIbiayi Dagogo-Jack, Marguerite Rooney, Jessica J Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 1, 2019
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK InhibitorsJessica J Lin, Adam J Schoenfeld, Viola W Zhu, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Plant Molecular Biology|May 15, 2002
Development and mapping of SSR markers for maizeNatalya Sharopova, Michael D McMullen, Linda Schultz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|March 19, 2020
Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with <i>RET</i> RearrangementsSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.
Clinical Lung Cancer|November 12, 2019
Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung CancerSubba R Digumarthy, Dexter P Mendoza, Jessica J Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2019
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLCIbiayi Dagogo-Jack, Marguerite Rooney, Rebecca J Nagy, et al.
Retrovirology|October 26, 2013
T cell response specificity and magnitude against SIVmac239 are not concordant in major histocompatibility complex-matched animalsBrian T Cain, Ngoc H Pham, Melisa L Budde, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung CancerJessica J Lin, Emily Chin, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation DiversityIbiayi Dagogo-Jack, Marguerite Rooney, Jessica J Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 1, 2019
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK InhibitorsJessica J Lin, Adam J Schoenfeld, Viola W Zhu, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
Plant Molecular Biology|May 15, 2002
Development and mapping of SSR markers for maizeNatalya Sharopova, Michael D McMullen, Linda Schultz, et al.
Pageof 3